1
|
Li ZM, Kuang YK, Zheng YF, Xu PH, Wang JY, Gan RJ, Li HX, Bai LH, Xie CM, Tang KJ. Gut-derived fungemia due to Kodamaea ohmeri combined with invasive pulmonary aspergillosis: a case report. BMC Infect Dis 2022; 22:903. [PMID: 36460998 PMCID: PMC9719164 DOI: 10.1186/s12879-022-07866-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Accepted: 11/10/2022] [Indexed: 12/04/2022] Open
Abstract
BACKGROUND Kodamaea ohmeri is a rare pathogen with high mortality and is found among blood samples in a considerable proportion; however, gastrointestinal infection of K. ohmeri is extremely rare. Invasive pulmonary aspergillosis is also an uncommon fungal; these two fungal infections reported concomitantly are unprecedented. CASE PRESENTATION We described a case of a 37-year-old male who got infected with K. ohmeri and invasive pulmonary aspergillosis. We used the mass spectrometry and histopathology to identify these two fungal infections separately. For the treatment of K. ohmeri, we chose caspofungin. As for invasive pulmonary aspergillosis, we used voriconazole, amphotericin B, and then surgery. The patient was treated successfully through the collaboration of multiple disciplines. CONCLUSIONS We speculate that the destruction of the intestinal mucosa barrier can make the intestine one of the ways for certain fungi to infect the human body.
Collapse
Affiliation(s)
- Zi-Mu Li
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Yu-Kun Kuang
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Yi-Fan Zheng
- grid.12981.330000 0001 2360 039XDepartment of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
| | - Pei-Hang Xu
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Ji-Yu Wang
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Run-Jing Gan
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Hui-Xia Li
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Li-Hong Bai
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Can-Mao Xie
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XInstitute of Pulmonary Diseases, Sun Yat-Sen University, Guangzhou, China
| | - Ke-Jing Tang
- grid.12981.330000 0001 2360 039XDivision of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Er Lu, Guangzhou, 510080 China ,grid.12981.330000 0001 2360 039XDepartment of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
| |
Collapse
|
2
|
Chang CC, Hall V, Cooper C, Grigoriadis G, Beardsley J, Sorrell TC, Heath CH. Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021. Intern Med J 2021; 51 Suppl 7:118-142. [PMID: 34937137 DOI: 10.1111/imj.15590] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Cryptococcosis caused by the Cryptococcus neoformans-Cryptococcus gattii complex is an important opportunistic infection in people with immunodeficiency, including in the haematology/oncology setting. This may manifest clinically as cryptococcal meningitis or pulmonary cryptococcosis, or be detected incidentally by cryptococcal antigenemia, a positive sputum culture or radiological imaging. Non-Candida, non-Cryptococcus spp. rare yeast fungaemia are increasingly common in this population. These consensus guidelines aim to provide clinicians working in the Australian and New Zealand haematology/oncology setting with clear guiding principles and practical recommendations for the management of cryptococcosis, while also highlighting important and emerging rare yeast infections and their recommended management.
Collapse
Affiliation(s)
- Christina C Chang
- Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.,Therapeutic and Vaccine Research Programme, Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.,Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu Natal, South Africa
| | - Victoria Hall
- Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.,Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada
| | - Celia Cooper
- Department of Microbiology and Infectious Diseases, Women's and Children's Hospital, North Adelaide, South Australia, Australia
| | - George Grigoriadis
- Monash Haematology, Monash Health, Melbourne, Victoria, Australia.,School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.,Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.,Department of Haematology, Alfred Hospital, Prahran, Victoria, Australia
| | - Justin Beardsley
- Marie Bashir Institute for Infectious Diseases & Biosecurity, University of Sydney, Sydney, New South Wales, Australia.,Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.,Department of Infectious Diseases, Prince of Wales Hospital, Randwick, New South Wales, Australia
| | - Tania C Sorrell
- Marie Bashir Institute for Infectious Diseases & Biosecurity, University of Sydney, Sydney, New South Wales, Australia.,Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.,Infectious Diseases and Sexual Health, Western Sydney Local Health District, Parramatta, New South Wales, Australia
| | - Christopher H Heath
- Department of Microbiology, Fiona Stanley Hospital Network, PathWest Laboratory Medicine, Murdoch, Western Australia, Australia.,Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.,Department of Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia.,Faculty of Health and Medical Sciences, University of Western Australia, Murdoch, Western Australia, Australia
| | | |
Collapse
|
3
|
Abstract
Background: Kodamaea ohmeri, previously known as Pichia ohmeri or Yamadazyma ohmeri, has been regarded as an emerging human pathogen in recent decades, and has caused various types of infections with high mortality. This study systematically reviewed all the published cases of K. ohmeri infection, aiming to have a better understanding of the clinical and epidemiological characteristics of the organism. Methods: All the published literature (as of March 31, 2021) on K. ohmeri, in four databases: PubMed, Embase, Web of Science, and CNKI, were systematically reviewed to select appropriate studies for summarizing the demographic information, clinical and microbiological characteristics of relevant infections. Results: A total of 51 studies involving 67 patients were included for final analysis, including 49 sporadic cases and two clusters of outbreaks. Neonates and the elderly constituted the majority of patients, and fungemia was the dominant infection type. Comorbidities (like malignancy, diabetes, and rheumatism), invasive operations, previous antibiotic use and prematurity, were commonly described in patients. Gene sequencing and broth microdilution method, were the most reliable way for the identification and antifungal susceptibility testing of K. ohmeri, respectively. Amphotericin B and fluconazole were the commonest antifungal therapies administered. The calculated mortality rates for K. ohmeri infection was higher than that of common candidemia. Conclusion: In this study, we systematically reviewed the epidemiology, clinical characteristics, microbiological features, treatment, and outcomes, of all the published cases on K. ohmeri. Early recognition and increased awareness of K. ohmeri as an emerging human pathogen by clinicians and microbiologists is important for effective management of this organism.
Collapse
Affiliation(s)
- Menglan Zhou
- Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.,Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing, China
| | - Yanbing Li
- Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.,Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing, China
| | - Timothy Kudinha
- School of Biomedical Sciences, Charles Sturt University, Orange, NSW, Australia.,NSW Health Pathology, Regional and Rural, Orange Base Hospital, Orange, NSW, Australia
| | - Yingchun Xu
- Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.,Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing, China
| | - Zhengyin Liu
- Department of Infectious Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
| |
Collapse
|
4
|
Kanno Y, Wakabayashi Y, Ikeda M, Tatsuno K, Misawa Y, Sato T, Yanagimoto S, Okugawa S, Moriya K, Yotsuyanagi H. Catheter-related bloodstream infection caused by Kodamaea ohmeri: A case report and literature review. J Infect Chemother 2017; 23:410-414. [PMID: 28188094 DOI: 10.1016/j.jiac.2017.01.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2016] [Revised: 12/27/2016] [Accepted: 01/15/2017] [Indexed: 01/05/2023]
Abstract
Kodamaea ohmeri is a rare yeast pathogen that has recently emerged as an important cause of fungemia in immunocompromised patients. However, appropriate therapy for this infection remains unclear. We report a case of catheter-related blood stream infection caused by K. ohmeri in a 58-year-old patient who improved after removal of the central venous catheter and administration of micafungin. Considering the antibiotic susceptibility of this pathogen and reviewing literature, echinocandins may be the first choice for an empiric therapy for this pathogen.
Collapse
Affiliation(s)
- Yoshiaki Kanno
- Department of Infectious Diseases, The University of Tokyo Hospital, Japan
| | | | - Mahoko Ikeda
- Department of Infectious Diseases, The University of Tokyo Hospital, Japan; Department of Infection Control and Prevention, The University of Tokyo Hospital, Japan
| | - Keita Tatsuno
- Department of Infectious Diseases, The University of Tokyo Hospital, Japan; Department of Infection Control and Prevention, The University of Tokyo Hospital, Japan
| | - Yoshiki Misawa
- Department of Infection Control and Prevention, The University of Tokyo Hospital, Japan
| | - Tomoaki Sato
- Department of Infection Control and Prevention, The University of Tokyo Hospital, Japan
| | | | - Shu Okugawa
- Department of Infectious Diseases, The University of Tokyo Hospital, Japan; Department of Infection Control and Prevention, The University of Tokyo Hospital, Japan.
| | - Kyoji Moriya
- Department of Infection Control and Prevention, The University of Tokyo Hospital, Japan
| | - Hiroshi Yotsuyanagi
- Department of Infectious Diseases, The University of Tokyo Hospital, Japan; The Advanced Clinical Research Center, Division of Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Japan
| |
Collapse
|
5
|
Giacobino J, Montelli AC, Barretti P, Bruder-Nascimento A, Caramori JT, Barbosa L, Bagagli E. Fungal peritonitis in patients undergoing peritoneal dialysis (PD) in Brazil: molecular identification, biofilm production and antifungal susceptibility of the agents. Med Mycol 2016; 54:725-732. [PMID: 27143636 DOI: 10.1093/mmy/myw030] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2015] [Accepted: 04/12/2016] [Indexed: 11/14/2022] Open
Abstract
This paper presents data on fungal peritonitis (FP) in patients undergoing peritoneal dialysis (PD) at the University Hospital of Botucatu Medical School, São Paulo, Brazil. In a total of 422 patients, 30 developed FP, from which the medical records and the fungal isolates of 23 patient cases were studied. All patients presented abdominal pain, cloudy peritoneal effluent, needed hospitalization, had the catheter removed and were treated with fluconazole or fluconazole plus 5-flucitosine; six of them died due to FP. Concerning the agents, it was observed that Candida parapsilosis was the leading species (9/23), followed by Candida albicans (5/23), Candida orthopsilosis (4/23), Candida tropicalis (3/23), Candida guilliermondii (1/23), and Kodamaea ohmeri (1/23). All the isolates were susceptible to amphotericin B, voriconazole and caspofungin whereas C. albicans isolates were susceptible to all antifungals tested. Resistance to fluconazole was observed in three isolates of C. orthopsilosis, and dose-dependent susceptibility to this antifungal was observed in two isolates of C. parapsilosis and in the K. ohmeri isolate. Biofilm production estimates were high or moderate in most isolates, especially in C. albicans species, and low in C. parapsilosis species, with a marked variation among the isolates. This Brazilian study reinforces that FP in PD is caused by a diverse group of yeasts, most prevalently C. parapsilosis sensu stricto species. In addition, they present significant variation in susceptibility to antifungals and biofilm production, thus contributing to the complexity and severity of the clinical features.
Collapse
Affiliation(s)
- Juliana Giacobino
- Departamento de Microbiologia e Imunologia, Instituto de Biociências, UNESP, Botucatu
| | | | - Pasqual Barretti
- Departamento de Clínica Médica, Faculdade de Medicina de Botucatu, UNESP
| | | | | | - Luciano Barbosa
- Departamento de Bioestatística, Instituto de Biociências, UNESP, Botucatu
| | - Eduardo Bagagli
- Departamento de Microbiologia e Imunologia, Instituto de Biociências, UNESP, Botucatu
| |
Collapse
|
6
|
|
7
|
Distasi MA, Del Gaudio T, Pellegrino G, Pirronti A, Passera M, Farina C. Fungemia due to Kodamaea ohmeri: First isolating in Italy. Case report and review of literature. J Mycol Med 2015; 25:310-6. [PMID: 26404421 DOI: 10.1016/j.mycmed.2015.08.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2014] [Revised: 08/02/2015] [Accepted: 08/08/2015] [Indexed: 01/28/2023]
Abstract
Kodamaea ohmeri, also known as Pichia ohmeri, is a yeast belonging to the Saccharomycetes family. In 2012, our hospital has recorded the first case of fungemia caused by K. ohmeri in an 80-year-old male, admitted to intensive care following an acute anterior-lateral myocardial infarction. K. ohmeri grew in blood cultures. Biochemical identification was confirmed using Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry and molecular sequencing. Antifungal susceptibility has been performed by broth dilution technique. This case confirms that K. ohmeri is an emergent pathogen even though rarely isolated in human disease. Permanent catheterization is a risk factor and may cause the persistence of a K. ohmeri infection, as well as support treatments (mechanical ventilation, tracheotomy, dialysis). Our therapeutic strategy has been empirical and based exclusively on tested antifungals MIC because EUCAST recommendations does not indicate breakpoints.
Collapse
Affiliation(s)
- M A Distasi
- UOC Patologia Clinica, Presidio Ospedaliero "Lorenzo Bonomo" ASL BT, Viale Istria, 1, 76123 Andria, Italy.
| | - T Del Gaudio
- UOC Patologia Clinica, Presidio Ospedaliero "Lorenzo Bonomo" ASL BT, Viale Istria, 1, 76123 Andria, Italy
| | - G Pellegrino
- UOC Patologia Clinica, Presidio Ospedaliero "Lorenzo Bonomo" ASL BT, Viale Istria, 1, 76123 Andria, Italy
| | - A Pirronti
- UOC Anestesia e Rianimazione, Presidio Ospedaliero "Lorenzo Bonomo" ASL BT, Viale Istria, 1, 76123 Andria, Italy
| | - M Passera
- USC Microbiologia e Virologia, Azienda Ospedaliera 'Papa Giovanni XXIII'; Piazza Organizzazione Mondiale della Sanità (OMS), 1, 24127 Bergamo, Italy
| | - C Farina
- USC Microbiologia e Virologia, Azienda Ospedaliera 'Papa Giovanni XXIII'; Piazza Organizzazione Mondiale della Sanità (OMS), 1, 24127 Bergamo, Italy
| |
Collapse
|
8
|
Chen SC, Sorrell TC, Chang CC, Paige EK, Bryant PA, Slavin MA. Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J 2015; 44:1315-32. [PMID: 25482743 DOI: 10.1111/imj.12597] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Pathogenic yeast forms are commonly associated with invasive fungal disease in the immunocompromised host, including patients with haematological malignancies and patients of haemopoietic stem cell transplants. Yeasts include the Candida spp., Cryptococcus spp., Pneumocystis jirovecii and some lesser-known pathogens. Candida species remain the most common cause of invasive yeast infections (and the most common human pathogenic fungi). These guidelines present evidence-based recommendations for the antifungal management of established, invasive yeast infections in adult and paediatric patients in the haematology/oncology setting. Consideration is also given to the critically ill patient in intensive care units, including the neonatal intensive care unit. Evidence for 'pre-emptive' or 'diagnostic-driven antifungal therapy' is also discussed. For the purposes of this paper, invasive yeast diseases are categorised under the headings of invasive candidiasis, cryptococcosis and uncommon yeast infections. Specific recommendations for the management of Pneumocystis jirovecii are presented in an accompanying article (see consensus guidelines by Cooley et al. appearing elsewhere in this supplement).
Collapse
Affiliation(s)
- S C Chen
- Centre for Infectious Diseases and Microbiology Laboratory Services, ICPMR - Pathology West, Westmead, New South Wales; Department of Infectious Diseases, Westmead Hospital, Westmead, New South Wales; Sydney Medical School, The University of Sydney, Sydney, New South Wales
| | | | | | | | | | | |
Collapse
|
9
|
Biswal D, Sahu M, Mahajan A, Advani SH, Shah S. Kodameae ohmeri - An Emerging Yeast: Two Cases and Literature Review. J Clin Diagn Res 2015; 9:DD01-3. [PMID: 25954619 DOI: 10.7860/jcdr/2015/11586.5661] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2014] [Accepted: 01/14/2015] [Indexed: 11/24/2022]
Abstract
Kodameae ohmeri is an emerging pathogen in various types of infections. Most infections are seen in patients with compromised immunity like cancer patients. Few cases of neonatal infections due to K. ohmeri have been reported earlier in premature neonates with fatal outcomes. We report two cases of fungemia; the first case was a patient with hematological malignancy, who complained of fever spikes and grew K. ohmeri in blood despite prophylactic voriconazole therapy. The second case was in a mature neonate, who developed respiratory distress and features of sepsis two days after birth, multiple blood cultures were positive for K. ohmeri. Both the patients responded well to Amphotericin B. Repeat blood cultures were sterile and patients were discharged. K. ohmeri is an unusual and emerging fungal pathogen of late an increasing number of cases of fungemia, funguria, endocarditis, peritonitis and wound infections due to the same are being reported. Some occur in immunocompromised patients and some inapparently immunocompetent patients, neonates with an inclination for preterm babies. We report two case of fungemia, one with lymphoma and the second in a neonate.
Collapse
Affiliation(s)
- Debadulal Biswal
- Senior Registrar, Department of Medical Oncology, S L Raheja Hospital , Mahim (W), Mumbai, Maharashtra, India
| | - Manisa Sahu
- Consultant, Department of Microbiology, S L Raheja Hospital , Mahim (W), Mumbai, Maharashtra, India
| | - Asmita Mahajan
- Consultant, Department of Neonatology, S L Raheja Hospital , Mahim (W), Mumbai, Maharashtra, India
| | - Suresh H Advani
- Consultant and Head, Department of Medical Oncology, S L Raheja Hospital , Mahim (W), Mumbai, Maharashtra, India
| | - Suresh Shah
- Consultant, Department of Paediatrics, S L Raheja Hospital , Mahim (W), Mumbai, Maharashtra, India
| |
Collapse
|
10
|
Santino I, Alari A, Bono S, Teti E, Marangi M, Bernardini A, Magrini L, Di Somma S, Teggi A. Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum. Int J Immunopathol Pharmacol 2014; 27:143-6. [PMID: 24674691 DOI: 10.1177/039463201402700120] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
The yeast Saccharomyces boulardii is a biotherapeutic agent used for the prevention and treatment of several gastrointestinal diseases, such as diarrhoea caused by Clostridium difficile, in addition to the antibiotic therapy. In this study we report a case of Saccharomyces cerevisiae fungemia in a patient with Clostridium difficile-associated diarrhoea (CDAD) treated orally with S. boulardii in association with vancomycin. The identification of the S. cerevisiae was confirmed by molecular technique. Fungemia is a rare, but a serious complication to treatment with probiotics. We believe it is important to remind the clinicians of this risk when prescribing probiotics, especially to immunocompromised patients.
Collapse
Affiliation(s)
- I Santino
- Department of Clinical and Molecular Medicine, Sapienza University of Rome, Italy
| | - A Alari
- Department of Clinical and Molecular Medicine, Sapienza University of Rome, Italy
| | - S Bono
- GENOMA Molecular Genetics Laboratory, Rome, Italy
| | - E Teti
- Department of Medical Sciences, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy
| | - M Marangi
- Department of Medical Sciences, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy
| | - A Bernardini
- Department of Emergency Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy
| | - L Magrini
- Department of Emergency Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy
| | - S Di Somma
- Department of Emergency Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy
| | - A Teggi
- Department of Medical Sciences, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy
| |
Collapse
|
11
|
Arendrup M, Boekhout T, Akova M, Meis J, Cornely O, Lortholary O. ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 2014; 20 Suppl 3:76-98. [DOI: 10.1111/1469-0691.12360] [Citation(s) in RCA: 350] [Impact Index Per Article: 35.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2013] [Revised: 08/16/2013] [Accepted: 08/16/2013] [Indexed: 12/27/2022]
|
12
|
Chakrabarti A, Rudramurthy S, Kale P, Hariprasath P, Dhaliwal M, Singhi S, Rao K. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin Microbiol Infect 2014; 20:O83-9. [DOI: 10.1111/1469-0691.12337] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2013] [Revised: 07/03/2013] [Accepted: 07/12/2013] [Indexed: 11/27/2022]
|